Environmental Factors in the Development of Polycystic Ovary Syndrome
NCT00341731 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-12-01
Summary
Polycystic Ovary Syndrome (PCOS) is manifested as a heterogeneous mixture of clinical and bichemical characteristics that complicate study of its etiology. It is currently unclear to what extent PCOS-associated traits (hyperandrogenism, hyperinsulinemia, insulin resistance, type 2 diabetes, dyslipidemia, hypertension, obesity, and coronary artery disease) are the result of environmental factors or genetic predisposition. We propose to conduct a twin study to investigate the possibility that environmental factors are important in the development of the PCOS phenotype. Twin studies are considered to be the gold standard for determining the extent of heritability of a trait. The proposal described here is only for Step 1 of a larger, multi-step study. The major goal of step 1 is to identify a large cohort of twin pairs, in which at least one member of each pair is likely to have PCOS.
Participants for this study will come from the Mid-Atlantic Twin Registry (MATR). Many (3283) potential participants have already been identified based on their answers to a preliminary MATR screening questionnaire. Out of the approximately 7145 twin women of reproductive age who completed these MATR screening questionnaires, 1803 women reported irregular periods, 954 reported ovarian cysts, and 526 reported both irregular periods and ovarian cysts. Many of the women in this last group are likely to have PCOS. They represent 7.4% of the total sample, matching current estimates of PCOS prevalence (4-7%) in reproductive age women. We will also add new twin pairs who meet the criteria (irregular periods and evidence of PCOS or cystic ovaries) as they are recruited into the MATR and take the preliminary surveys. According to MATR statistics, about 33% of twin pairs are monozygotic (MZ, identical). Therefore, approximately 174 of the 526 women likely to have PCOS are members of a MZ pair.
Step 1 of the proposed study consists of a telephone survey of the 3282 women with irregular periods and/or ovarian cysts. The survey will be conducted by the MATR. The instrument to be used contains a series of simple and direct questions and will take about 10 minutes to complete. The questions were designed to identify PCOS and their content deals with the frequency of menstrual periods (six or fewer per year being a major diagnostic criterion), a previous diagnosis of PCOS, obesity, excess facial hair and other evidence of hyperandrogenism. The women will also be asked if t...
Conditions
- Polycystic Ovary Syndrome
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-12-31
Countries
- United States
Study Locations
More Related Trials
-
Genetics of Polycystic Ovary Syndrome
NCT00647335 ·Status: COMPLETED
-
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
NCT02145247 ·Status: COMPLETED ·Phase: NA
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN
-
Characterization of a Prospective Cohort of Women With PCOS
NCT02010814 ·Status: RECRUITING
-
The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
NCT03843736 ·Status: UNKNOWN ·Phase: PHASE3
-
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
NCT01899001 ·Status: COMPLETED ·Phase: NA
-
Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin
NCT03483792 ·Status: COMPLETED
-
Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome
NCT01475565 ·Status: TERMINATED
-
The Impact of Time-restricted Eating on the Outcomes Associated With Polycystic Ovary Syndrome
NCT06204965 ·Status: RECRUITING ·Phase: NA
-
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342 ·Status: UNKNOWN
-
A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype
NCT04981275 ·Status: COMPLETED
-
Compromised Microcirculation in Women With Polycystic Ovary Syndrome
NCT00757185 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Influence of Polycystic Ovairan Syndrome on Embryonic Developmental Timing
NCT01953146 ·Status: COMPLETED
-
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
NCT01482286 ·Status: TERMINATED ·Phase: PHASE3
-
Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)
NCT00606671 ·Status: COMPLETED
-
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
NCT03911297 ·Status: RECRUITING
-
Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome
NCT02513381 ·Status: COMPLETED ·Phase: NA
-
Children Follow-up of PCOS Women
NCT01767051 ·Status: COMPLETED
-
The Role of Insulin Resistance in PCOS
NCT00173043 ·Status: UNKNOWN
-
Gut Microbiome in Patients With Polycystic Ovary Syndrome
NCT02078505 ·Status: UNKNOWN ·Phase: NA
-
Oral Administration of DCI to Women With PCOS
NCT00497653 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Oral Contraceptive and Cardiovascular Risk in PCOS
NCT00593294 ·Status: COMPLETED ·Phase: PHASE4
-
PCOS, Therapy and Markers of Cardiovascular Risk
NCT01798875 ·Status: UNKNOWN ·Phase: PHASE4
-
Reproductive Axis Maturation in the Early Post-Menarchal Years
NCT03986021 ·Status: RECRUITING
-
Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.
NCT06551285 ·Status: RECRUITING ·Phase: NA